Enovis (ENOV) EBITDA Margin (2010 - 2026)
Enovis' (ENOV) quarterly EBITDA Margin came in at 2.99% in Q3 2026, up 596.0% year-over-year from 0.43% in Q3 2025, and up 169.58% quarter-over-quarter from 1.11% in Q2 2026.
Powered by 
Analysis
Enovis (ENOV) EBITDA Margin (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported EBITDA Margin for 17 consecutive years, with 2.99% the latest figure, recorded in Q3 2026.
- On a quarterly basis, EBITDA Margin rose 596.0% year-over-year to 2.99% in Q3 2026; TTM through Jul 2026 was 45.14%, a 1043.0% decrease from a year earlier, with the FY2025 full-year figure at 50.01%, down 1320.0% from the prior year.
- EBITDA Margin was 2.99% for Q3 2026 at Enovis, up from 1.11% in the prior quarter.
- Over five years, EBITDA Margin peaked at 2.99% in Q3 2026 and troughed at 118.5% in Q4 2024.
- A 5-year average of 20.57% and a median of 6.21% in 2023 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin plunged 11723 bps in 2024 and jumped 3128 bps in 2025, its largest moves.
- Over 5 years, EBITDA Margin stood at 6.9% in 2022, then soared by 82 bps to 1.26% in 2023, then tumbled by 9269 bps to 118.5% in 2024, then increased by 26 bps to 87.22% in 2025, then surged by 103 bps to 2.99% in 2026.
- The last three EBITDA Margin figures came in at 2.99% (Q3 2026), 1.11% (Q2 2026), and 87.22% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 19.15% |
| 10 | Enovis | 1.07 Bn | 1.06 Bn | 359.25 Mn | 2.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 2.99% |
| Apr 3, 2026 | 1.11% |
| Dec 31, 2025 | -87.22% |
| Oct 3, 2025 | -101.74% |
| Jul 4, 2025 | -2.98% |
| Apr 4, 2025 | -8.37% |
| Dec 31, 2024 | -118.50% |
| Sep 27, 2024 | -6.28% |
| Jun 28, 2024 | -8.42% |
| Mar 29, 2024 | -6.78% |
| Dec 31, 2023 | -1.26% |
| Sep 29, 2023 | -4.91% |
| Jun 30, 2023 | -3.38% |
| Mar 31, 2023 | -6.15% |
| Dec 31, 2022 | -6.90% |
| Sep 30, 2022 | -4.67% |
| Jul 1, 2022 | 1.41% |
| Apr 1, 2022 | -8.16% |
| Dec 31, 2021 | -4.56% |
| Oct 1, 2021 | -4.48% |